authors
- Macaulay, VM
- Middleton, MR
- Eckhardt, SG
- Juergens, Rosalyn
- Rudin, CM
- Manukyants, A
- Gogov, S
- Poondru, S
- Gedrich, R
- Gadgeel, SM
Phase I study of OSI-906, dual tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR) in combination with erlotinib (E) in patients with advanced solid tumors.
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- May 20, 2011
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal